JP7570677B2 - Skin cosmetics - Google Patents
Skin cosmetics Download PDFInfo
- Publication number
- JP7570677B2 JP7570677B2 JP2020196136A JP2020196136A JP7570677B2 JP 7570677 B2 JP7570677 B2 JP 7570677B2 JP 2020196136 A JP2020196136 A JP 2020196136A JP 2020196136 A JP2020196136 A JP 2020196136A JP 7570677 B2 JP7570677 B2 JP 7570677B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- component
- present
- thickness
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 50
- 229920001577 copolymer Polymers 0.000 claims description 17
- 229920006037 cross link polymer Polymers 0.000 claims description 15
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 13
- -1 alkyl glucoside Chemical class 0.000 claims description 11
- 229930182478 glucoside Natural products 0.000 claims description 7
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 6
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 claims description 5
- KIOWXTOCDZJCBM-UHFFFAOYSA-N 2-docosoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KIOWXTOCDZJCBM-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 5
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 5
- 229940110830 beheneth-25 methacrylate Drugs 0.000 claims description 5
- 229940100485 methyl gluceth-10 Drugs 0.000 claims description 5
- 229940031722 methyl gluceth-20 Drugs 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000011156 evaluation Methods 0.000 description 16
- 230000002459 sustained effect Effects 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 10
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 7
- 230000005923 long-lasting effect Effects 0.000 description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 229940043348 myristyl alcohol Drugs 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- JDRSMPFHFNXQRB-IWQYDBTJSA-N (3r,4s,5s,6r)-2-decoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group CCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IWQYDBTJSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 229940048053 acrylate Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 229940106010 beheneth-25 Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は皮膚化粧料に関し、特に塗布時の厚みがあり、肌へのなじみとのびが良好であり、べたつかず、しっとり感が持続する皮膚化粧料に関する。 The present invention relates to skin cosmetics, and in particular to skin cosmetics that are thick when applied, have good affinity and spreadability on the skin, are not sticky, and provide a long-lasting moist feeling.
近年、皮膚化粧料は肌の状態を保持または改善する効能に加え、消費者の趣向から様々な使用感が求められている。皮膚化粧料の使用感の中でも、塗布する際に厚みを感じることができる使用感は化粧料自体に高級さを感じられることから消費者の需要が高い。 In recent years, in addition to the efficacy of maintaining or improving skin condition, skin cosmetics are being sought after for a variety of usability features in response to consumer preferences. Among the usability features of skin cosmetics, there is high demand from consumers for a usability that gives the cosmetic a sense of luxury when applied.
従来、皮膚化粧料は塗布時の厚みを出す目的で増粘剤が用いられてきた。増粘剤を配合した皮膚化粧料は塗布時の厚みを向上させるが、増粘剤の配合量が多すぎると肌へのなじみやのびが悪くなり、またべたつきが生じる等の使用感に問題がある。 Conventionally, thickeners have been used in skin cosmetics to increase the thickness of the skin when applied. Skin cosmetics containing thickeners increase the thickness of the skin when applied, but if too much thickener is used, the skin does not blend well or spread well, and there are problems with the feel when used, such as stickiness.
特許文献1では常温固形油である高級脂肪酸および高級アルコール、界面活性剤、アクリルアミド系増粘剤、ヒドロキシプロピルメチルセルロースを配合することを特徴とする水中油型乳化化粧料が、塗布時の厚み、肌へのなじみ、べたつきが改善し、のびがやや改善することを開示している。 Patent Document 1 discloses that an oil-in-water emulsion cosmetic, which is characterized by the blending of higher fatty acids and higher alcohols that are solid at room temperature, a surfactant, an acrylamide thickener, and hydroxypropyl methylcellulose, has improved thickness when applied, compatibility with the skin, stickiness, and slightly improved spreadability.
特許文献2ではアルキルグルコシド誘導体、ポリエチレングリコール、高分子化合物を配合することを特徴とする皮膚化粧料が、塗布時の厚み、のび、べたつき、しっとり感の持続性が改善することを開示している。 Patent Document 2 discloses that a skin cosmetic preparation characterized by containing an alkyl glucoside derivative, polyethylene glycol, and a polymeric compound improves the thickness, spread, stickiness, and sustained moist feeling when applied.
特許文献3では多価アルコールおよび/またはアミノ酸、ポリオキシアルキレンアルキルグルコシド、ポリオキシエチレンソルビトール脂肪酸エステル、水溶性ポリマーを配合することを特徴とする皮膚用化粧料が、塗布時の厚み、肌へのなじみ、べたつき、しっとり感の持続性が改善することを開示している。 Patent Document 3 discloses that a skin cosmetic preparation characterized by containing a polyhydric alcohol and/or an amino acid, a polyoxyalkylene alkyl glucoside, a polyoxyethylene sorbitol fatty acid ester, and a water-soluble polymer improves the thickness upon application, compatibility with the skin, stickiness, and sustained moist feeling.
しかしながら、特許文献1から特許文献3では塗布時の厚み、肌へのなじみ、のびの良さ、べたつきのなさおよびしっとり感の持続性の全てを十分に満たす皮膚化粧料の検討が不十分であり、検討の余地がある。 However, Patent Documents 1 to 3 do not fully explore skin cosmetics that fully satisfy all of the following requirements: thickness when applied, compatibility with the skin, good spreadability, non-stickiness, and sustained moisturizing sensation, and further study is needed.
本発明は塗布時の厚みがあり、肌へのなじみとのびが良好であり、べたつかず、しっとり感が持続する皮膚化粧料を提供することを課題とする。 The objective of the present invention is to provide a skin cosmetic that is thick when applied, spreads well on the skin, is not sticky, and provides a long-lasting moist feeling.
本発明者は、(A)(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー、(B)(A)成分以外のアクリロイルジメチルタウリン塩共重合体またはアクリル酸・メタクリル酸アルキル共重合体から選ばれる1種以上、(C)アルキルグルコシド誘導体、(D)炭素数12~24の高級アルコールを含有する皮膚化粧料に塗布時の厚みがあり、肌へのなじみとのびが良好であり、べたつかず、しっとり感が持続する皮膚化粧料が得られることを見出し、本発明を完成するに至った。 The present inventors have discovered that a skin cosmetic containing (A) an (ammonium acryloyldimethyltaurate/VP) copolymer, (B) one or more selected from an acryloyldimethyltaurate salt copolymer other than component (A) or an acrylic acid/alkyl methacrylate copolymer, (C) an alkyl glucoside derivative, and (D) a higher alcohol having 12 to 24 carbon atoms has a good thickness when applied, is well absorbed and spreads on the skin, is not sticky, and provides a long-lasting moist feeling, leading to the completion of the present invention.
本発明により、塗布時の厚みがあり、肌へのなじみとのびが良好であり、べたつかず、しっとり感が持続する皮膚化粧料を提供する。 The present invention provides a skin cosmetic that is thick when applied, spreads well on the skin, is not sticky, and provides a long-lasting moist feeling.
以下、本発明を詳細に説明する。なお、含有量を示す単位は、特に明記しない限り全て質量%である。 The present invention will be described in detail below. Note that all units indicating content are mass% unless otherwise specified.
本発明は、肌へのなじみおよびのびの良さの観点から、(A)(アクリロイルジメチルタウリンアンモニウム/VP)コポリマーを含有する。 The present invention contains (A) (ammonium acryloyldimethyltaurate/VP) copolymer from the viewpoint of compatibility with the skin and ease of spreading.
本発明で用いられる前記(A)成分の含有量は、好ましくは0.01~1%、より好ましくは0.02~0.5%、さらに好ましくは0.05~0.3%がよい。前記(A)成分が0.01%未満の場合、肌へのなじみおよびのびの良さが得られない恐れがある。前記(A)成分が1%を超える場合、皮膚化粧料が硬くなるため、肌へのなじみおよびのびが悪くなる恐れや、べたつきが生じる恐れがある。 The content of the component (A) used in the present invention is preferably 0.01 to 1%, more preferably 0.02 to 0.5%, and even more preferably 0.05 to 0.3%. If the content of the component (A) is less than 0.01%, there is a risk that the skin will not blend well and spread well. If the content of the component (A) is more than 1%, the skin cosmetic will harden, which may result in poor blending and spreading on the skin and stickiness.
本発明は、塗布時の厚み、肌へのなじみ、のびの良さおよびしっとり感の持続の観点から、(B)(A)成分以外のアクリロイルジメチルタウリン塩共重合体またはアクリル酸・メタクリル酸アルキル共重合体から選ばれる1種以上を含有する。 From the viewpoints of thickness when applied, compatibility with the skin, good spreadability, and sustained moist feeling, the present invention contains (B) one or more selected from acryloyldimethyltaurate salt copolymers other than component (A) or acrylic acid/alkyl methacrylate copolymers.
本発明で用いられる前記(B)成分の(A)成分以外のアクリロイルジメチルタウリン塩共重合体としては、特に限定されないが、例えば、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマー、(HEA/アクリロイルジメチルタウリンNa/メタクリル酸ステアレス-20)コポリマー、(アクリルアミド/アクリロイルジメチルタウリンNa/アクリル酸)コポリマー、(アクリルアミド/アクリロイルジメチルタウリンNa)コポリマー、(アクリル酸Na/アクリロイルジメチルタウリンNa/アクリルアミド)コポリマー、(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー、(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、(アクリロイルジメチルタウリンNa/ジアクリル酸PEG-8)クロスポリマー、(アクリロイルジメチルタウリンNa/メタクリルアミドラウリン酸)コポリマー、(アクリロイルジメチルタウリンアンモニウム/アクリル酸カルボキシエチルアンモニウム)クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ステアレス-25)クロスポリマー、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ステアレス-8)コポリマー、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ラウレス-7)コポリマー、(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポリマー、ポリアクリロイルジメチルタウリンNa、ポリアクリロイルジメチルタウリンアンモニウム、ポリアクリレートクロスポリマー-6、ポリアクリレートクロスポリマー-11、ポリアクリレート-13等が挙げられる。 The acryloyldimethyltaurate salt copolymer other than the component (A) of the component (B) used in the present invention is not particularly limited, but may be, for example, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer, (HEA/sodium acryloyldimethyltaurate/steareth-20 methacrylate) copolymer, (acrylamide/sodium acryloyldimethyltaurate/acrylic acid) copolymer, (acrylamide/sodium acryloyldimethyltaurate) copolymer, (sodium acrylate/sodium acryloyldimethyltaurate/acrylamide) copolymer, (sodium acrylate/sodium acryloyldimethyltaurate) copolymer, (hydroxyethyl acrylate/sodium acryloyldimethyltaurate) copolymer, (sodium acryloyldimethyltaurate/PEG-8 diacrylate) Examples of such crosspolymers include (sodium acryloyldimethyltaurate/methacrylamidolauric acid) copolymer, (ammonium acryloyldimethyltaurate/carboxyethylammonium acrylate) crosspolymer, (ammonium acryloyldimethyltaurate/steareth-25 methacrylate) crosspolymer, (ammonium acryloyldimethyltaurate/steareth-8 methacrylate) copolymer, (ammonium acryloyldimethyltaurate/laureth-7 methacrylate) copolymer, (dimethylacrylamide/sodium acryloyldimethyltaurate) crosspolymer, sodium polyacryloyldimethyltaurate, ammonium polyacryloyldimethyltaurate, polyacrylate crosspolymer-6, polyacrylate crosspolymer-11, and polyacrylate-13.
本発明で用いられる前記(B)成分のアクリル酸・メタクリル酸アルキル共重合体としては、特に限定されないが、例えば、(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマーが挙げられる。 The acrylic acid/alkyl methacrylate copolymer of component (B) used in the present invention is not particularly limited, but examples thereof include (acrylates/alkyl acrylate (C10-30)) crosspolymer.
本発明に用いられる前記(B)成分のうち、塗布時の厚み、肌へのなじみ、のびの良さおよびしっとり感の持続の観点から、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマー、(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマーが好ましく、中でも(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマーが好ましい。 Among the components (B) used in the present invention, from the viewpoints of thickness upon application, compatibility with the skin, good spreadability, and sustained moisturizing sensation, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer and (acrylates/alkyl acrylate (C10-30)) crosspolymer are preferred, and among these, (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer is preferred.
本発明に用いられる前記(B)成分のうち、肌へのなじみを向上させる観点から、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマーおよび(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマーを併用することが好ましい。 Among the components (B) used in the present invention, it is preferable to use (ammonium acryloyldimethyltaurate/beheneth-25 methacrylate) crosspolymer and (acrylates/alkyl acrylate (C10-30)) crosspolymer in combination in order to improve compatibility with the skin.
本発明で用いられる前記(B)成分の含有量は、好ましくは0.01~1%、より好ましくは0.02~0.5%、さらに好ましくは0.05~0.4%がよい。前記(B)成分が0.01%未満の場合、塗布時の厚み、肌へのなじみ、のびの良さおよびしっとり感の持続が得られない恐れがある。前記(B)成分が1%を超える場合、皮膚化粧料が硬くなるため、肌へのなじみおよびのびが悪くなる恐れや、べたつきが生じる恐れがある。 The content of the (B) component used in the present invention is preferably 0.01 to 1%, more preferably 0.02 to 0.5%, and even more preferably 0.05 to 0.4%. If the (B) component is less than 0.01%, there is a risk that the thickness upon application, compatibility with the skin, good spreadability, and sustained moist feeling may not be obtained. If the (B) component is more than 1%, the skin cosmetic may become hard, which may result in poor compatibility and spreadability on the skin, and stickiness.
本発明は、塗布時の厚みおよびしっとり感の持続の観点から、(C)アルキルグルコシド誘導体を含有する。 The present invention contains (C) an alkyl glucoside derivative from the viewpoints of thickness upon application and sustained moist feeling.
本発明で用いられる前記(C)成分としては、特に限定されないが、例えば、メチルグルセス-10、メチルグルセス-20、PPG-10メチルグルコース、PPG-20メチルグルコース、アルキル(C12-20)グルコシド、デシルグルコシド、ヒドロキシステアリルグルコシド、ポリオキシプロピレンカルボキシアルキル(C14-18)ジグルコシド、ラウリルグルコシド、(C12-20)アルキルグルコシド等が挙げられる。前記(C)成分は1種以上を含有してよい。 The component (C) used in the present invention is not particularly limited, but examples thereof include methyl gluceth-10, methyl gluceth-20, PPG-10 methyl glucose, PPG-20 methyl glucose, alkyl (C12-20) glucoside, decyl glucoside, hydroxystearyl glucoside, polyoxypropylene carboxyalkyl (C14-18) diglucoside, lauryl glucoside, and (C12-20) alkyl glucoside. The component (C) may contain one or more types.
本発明に用いられる前記(C)成分のうち、塗布時の厚みおよびしっとり感の持続の観点からメチルグルセス-10、メチルグルセス-20、PPG-10メチルグルコース、PPG-20メチルグルコースが好ましく、中でもメチルグルセス-10、メチルグルセス-20が好ましい。 Among the components (C) used in the present invention, methyl gluceth-10, methyl gluceth-20, PPG-10 methyl glucose, and PPG-20 methyl glucose are preferred from the viewpoints of thickness upon application and sustained moisturizing feeling, with methyl gluceth-10 and methyl gluceth-20 being particularly preferred.
本発明で用いられる前記(C)成分の含有量は、好ましくは0.1~15%、より好ましくは0.5~8%、さらに好ましくは1~4%がよい。前記(C)成分が0.1%未満の場合、塗布時の厚みおよびしっとり感の持続が得られない恐れがある。前記(C)成分が15%を超える場合、皮膚化粧料の粘性が高くなるため、肌へのなじみおよびのびが悪くなる恐れや、べたつきが生じる恐れがある。 The content of the (C) component used in the present invention is preferably 0.1 to 15%, more preferably 0.5 to 8%, and even more preferably 1 to 4%. If the (C) component is less than 0.1%, there is a risk that the thickness upon application and the moist feeling will not be sustained. If the (C) component is more than 15%, the viscosity of the skin cosmetic will increase, which may result in poor compatibility and spreadability on the skin, and stickiness.
本発明は、塗布時の厚みおよびべたつきのなさの観点から、(D)炭素数12~24の高級アルコールを含有する。 The present invention contains (D) a higher alcohol having 12 to 24 carbon atoms from the viewpoints of thickness and non-stickiness when applied.
本発明で用いられる前記(D)成分としては、特に限定されないが、例えば、ラウリルアルコール、ミリスチルアルコール、セタノール、ステアリルアルコール、アラキルアルコール、ベヘニルアルコール、2-デシルテトラデカノール等が挙げられる。前記(D)成分は1種以上を含有してよい。 The component (D) used in the present invention is not particularly limited, but examples thereof include lauryl alcohol, myristyl alcohol, cetanol, stearyl alcohol, arachyl alcohol, behenyl alcohol, and 2-decyltetradecanol. The component (D) may contain one or more types.
本発明に用いられる前記(D)成分のうち、べたつきのなさの観点からミリスチルアルコール、セタノール、ステアリルアルコール、ベヘニルアルコールが好ましく、中でもミリスチルアルコールが好ましい。 Among the components (D) used in the present invention, myristyl alcohol, cetanol, stearyl alcohol, and behenyl alcohol are preferred from the viewpoint of non-stickiness, and myristyl alcohol is particularly preferred.
本発明で用いられる前記(D)成分の含有量は、好ましくは0.05~4%、より好ましくは0.1~2%、さらに好ましくは0.3~1%がよい。前記(D)成分が0.05%未満の場合、塗布時の厚みが得られない恐れや、べたつきが生じる恐れがある。前記(D)成分が4%を超える場合、皮膚化粧料が硬くなるため、肌へのなじみおよびのびが悪くなる恐れや、べたつきが生じる恐れがある。 The content of the (D) component used in the present invention is preferably 0.05 to 4%, more preferably 0.1 to 2%, and even more preferably 0.3 to 1%. If the (D) component is less than 0.05%, there is a risk that the desired thickness may not be achieved upon application, or that stickiness may occur. If the (D) component is more than 4%, the skin cosmetic may become hard, resulting in poor compatibility and spreadability on the skin, or stickiness.
本発明における皮膚化粧料の粘度は、指取れ性の観点から、20℃の条件下で2,000~40,000mPa・sであることが好ましい。粘度が2,000mPa・s未満の場合、皮膚化粧料が液だれしやすくなるため、指取れ性が悪くなる恐れがある。粘度が40,000mPa・sを超える場合、皮膚化粧料が硬くなるため、指取れ性が悪くなる恐れがある。 From the viewpoint of ease of removal from fingers, the viscosity of the skin cosmetic of the present invention is preferably 2,000 to 40,000 mPa·s at 20°C. If the viscosity is less than 2,000 mPa·s, the skin cosmetic may be prone to dripping, resulting in poor removal from fingers. If the viscosity exceeds 40,000 mPa·s, the skin cosmetic may become hard, resulting in poor removal from fingers.
本発明における皮膚化粧料の20℃の条件下における粘度は、常法にて調製して得られた皮膚化粧料を140g容量のサンプル瓶(食品140:第一硝子株式会社製)に120g充填し、20℃で1日間放置し調温した後に、ヘリカルスタンド付B型粘度計(モデル:デジタル粘度計TVB-10M、東機産業株式会社製)により、4号ローターにて1分間、回転速度12rpmの条件下で測定したものである。 The viscosity of the skin cosmetic of the present invention at 20°C was measured by filling a 140g sample bottle (Food 140: manufactured by Daiichi Glass Co., Ltd.) with 120g of the skin cosmetic prepared by conventional methods, leaving it at 20°C for one day to adjust the temperature, and then measuring the viscosity at 20°C for one minute using a No. 4 rotor at a rotation speed of 12 rpm using a B-type viscometer with a helical stand (Model: Digital Viscometer TVB-10M, manufactured by Toki Sangyo Co., Ltd.).
本発明における皮膚化粧料のpHは、乳化安定性の観点から、20℃の条件下で4~9であることが好ましい。皮膚化粧料のpHが4未満または9を超える場合、乳化安定性が悪くなる恐れがある。 From the viewpoint of emulsion stability, the pH of the skin cosmetic of the present invention is preferably 4 to 9 at 20°C. If the pH of the skin cosmetic is less than 4 or exceeds 9, the emulsion stability may be deteriorated.
本発明における乳化安定性とは、皮膚化粧料を140g容量のサンプル瓶(食品140:第一硝子株式会社製)に120g入れ、40℃の恒温槽中に30日間保存し、恒温槽から取り出した皮膚化粧料が分離しているか否かである。 In the present invention, emulsion stability refers to whether or not the skin cosmetic is separated when 120 g of the skin cosmetic is placed in a 140 g sample bottle (Food 140: manufactured by Daiichi Glass Co., Ltd.) and stored in a constant temperature bath at 40°C for 30 days and removed from the constant temperature bath.
本発明における皮膚化粧料の20℃の条件下でのpHは、常法にて調製して得られた皮膚化粧料を20℃で1日間静置し調温した後に、ガラス電極式水素イオン濃度指示計(F-71、株式会社堀場製作所製)にて測定したものである。 The pH of the skin cosmetic of the present invention at 20°C was measured using a glass electrode type hydrogen ion concentration indicator (F-71, manufactured by Horiba, Ltd.) after the skin cosmetic prepared by a conventional method was left to stand at 20°C for one day and the temperature was adjusted.
本発明の皮膚化粧料は前記必須成分の他に、通常の化粧料、医薬部外品、医薬品等に用いられる各種成分、例えば、界面活性剤、油性成分、前記(C)成分以外の保湿剤、キレート剤、薬効成分、蛋白誘導体、加水分解蛋白、安定化剤、酸化防止剤、植物性抽出物、生薬抽出物、ビタミン類、防腐剤、色素、顔料、粉体、紫外線吸収剤、香料等から選ばれる少なくとも1種以上を効果を損なわない範囲で含有することができる。ただし、これら例示に限定されるものではない。 In addition to the essential components, the skin cosmetic of the present invention may contain at least one selected from various components used in ordinary cosmetics, quasi-drugs, pharmaceuticals, etc., such as surfactants, oily components, moisturizers other than component (C), chelating agents, medicinal ingredients, protein derivatives, hydrolyzed proteins, stabilizers, antioxidants, plant extracts, herbal extracts, vitamins, preservatives, dyes, pigments, powders, UV absorbers, fragrances, etc., to the extent that the effects are not impaired. However, the components are not limited to these examples.
以下に実施例を挙げて本発明をさらに詳細に説明するが、これらは本発明を何ら限定するものではない。 The present invention will be described in more detail below with reference to examples, but these are not intended to limit the present invention in any way.
本明細書に示す評価試験において、皮膚化粧料に含まれる成分、およびその含有量を種々変更しながら実施した。 The evaluation tests shown in this specification were carried out while varying the ingredients contained in the skin cosmetics and their contents.
本明細書に示す評価試験方法において、「塗布時の厚み」、「肌へのなじみ」、「のびの良さ」、「べたつきのなさ」および「しっとり感の持続」について下記の方法で評価した。 In the evaluation test methods shown in this specification, "thickness when applied," "compatibility with the skin," "ease of spreading," "non-stickiness," and "lasting moist feeling" were evaluated using the following methods.
「塗布時の厚み」
実施例および比較例で得られた皮膚化粧料の塗布時の厚みを専門のパネラー15人で評価試験を行った。評価試験は、20℃に調温した実施例および比較例の皮膚化粧料1gを室温20℃、湿度60%の条件下で顔全体に均一に塗布し、塗布時の厚みがあるか否かを官能にて評価した。
<評価基準>
5:15人中13人以上が塗布時の厚みがあると感じた。
4:15人中10人以上12人以下が塗布時の厚みがあると感じた。
3:15人中7人以上9人以下が塗布時の厚みがあると感じた。
2:15人中4人以上6人以下が塗布時の厚みがあると感じた。
1:15人中3人以下が塗布時の厚みがあると感じた。
"Thickness when applied"
A panel of 15 experts evaluated the thickness of the skin cosmetics obtained in the Examples and Comparative Examples when applied. In the evaluation test, 1 g of the skin cosmetics of the Examples and Comparative Examples, which had been adjusted to 20° C., was applied evenly to the entire face under conditions of room temperature of 20° C. and humidity of 60%, and the thickness when applied was evaluated by sensory evaluation.
<Evaluation criteria>
5: 13 or more out of 15 people felt that the product was thick when applied.
4: Between 10 and 12 out of 15 people felt that the coating was too thick when applied.
3: 7 to 9 out of 15 people felt that the coating was thick when applied.
2: Of 15 people, between 4 and 6 felt that the coating was too thick when applied.
1: 3 or less out of 15 people felt that the product was too thick when applied.
「肌へのなじみ」
実施例および比較例で得られた皮膚化粧料の肌へのなじみを専門のパネラー15人で評価試験を行った。評価試験は、20℃に調温した実施例および比較例の皮膚化粧料1gを室温20℃、湿度60%の条件下で顔全体に均一に塗布し、塗布時の肌へのなじみが良いか否かを官能にて評価した。
<評価基準>
5:15人中13人以上が肌へのなじみが良いと感じた。
4:15人中10人以上12人以下が肌へのなじみが良いと感じた。
3:15人中7人以上9人以下が肌へのなじみが良いと感じた。
2:15人中4人以上6人以下が肌へのなじみが良いと感じた。
1:15人中3人以下が肌へのなじみが良いと感じた。
"Skin-friendly"
A panel of 15 experts evaluated the compatibility of the skin cosmetics obtained in the Examples and Comparative Examples with the skin. In the evaluation test, 1 g of the skin cosmetics of the Examples and Comparative Examples, adjusted to 20° C., was applied evenly to the entire face under conditions of room temperature of 20° C. and humidity of 60%, and the compatibility of the cosmetics with the skin upon application was evaluated by sensory evaluation.
<Evaluation criteria>
5: More than 13 out of 15 people felt that the product blended well with the skin.
4: Between 10 and 12 out of 15 people felt that the product blended well with the skin.
3: Between 7 and 9 out of 15 people felt that the product blended well with their skin.
2: Between 4 and 6 out of 15 people felt that the product blended well with the skin.
1: Less than 3 out of 15 people felt that the product blended well with the skin.
「のびの良さ」
実施例および比較例で得られた皮膚化粧料ののびの良さを専門のパネラー15人で評価試験を行った。評価試験は、20℃に調温した実施例および比較例の皮膚化粧料1gを室温20℃、湿度60%の条件下で顔全体に均一に塗布し、塗布時ののびが良いか否かを官能にて評価した。
<評価基準>
5:15人中13人以上がのびが良いと感じた。
4:15人中10人以上12人以下がのびが良いと感じた。
3:15人中7人以上9人以下がのびが良いと感じた。
2:15人中4人以上6人以下がのびが良いと感じた。
1:15人中3人以下がのびが良いと感じた。
"Good stretchiness"
A panel of 15 experts evaluated the spreadability of the skin cosmetics obtained in the Examples and Comparative Examples. In the evaluation test, 1 g of the skin cosmetics of the Examples and Comparative Examples, which had been adjusted to 20° C., was applied evenly to the entire face under conditions of room temperature of 20° C. and humidity of 60%, and the spreadability upon application was evaluated by sensory evaluation.
<Evaluation criteria>
5: More than 13 out of 15 people felt that it stretched well.
4: Of 15 people, between 10 and 12 felt that the stretch was good.
3: Of the 15 people, between 7 and 9 felt that the stretch was good.
2: Of the 15 people, between 4 and 6 felt that the stretch was good.
1: Fewer than 3 out of 15 people felt that the stretch was good.
「べたつきのなさ」
実施例および比較例で得られた皮膚化粧料のべたつきを専門のパネラー15人で評価試験を行った。評価試験は、20℃に調温した実施例および比較例の皮膚化粧料1gを室温20℃、湿度60%の条件下で顔全体に均一に塗布し、べたつきを感じるか否かを官能にて評価した。
<評価基準>
5:15人中13人以上がべたつきを感じなかった。
4:15人中10人以上12人以下がべたつきを感じなかった。
3:15人中7人以上9人以下がべたつきを感じなかった。
2:15人中4人以上6人以下がべたつきを感じなかった。
1:15人中3人以下がべたつきを感じなかった。
"Non-sticky"
The stickiness of the skin cosmetics obtained in the Examples and Comparative Examples was evaluated by a panel of 15 experts. In the evaluation test, 1 g of the skin cosmetics of the Examples and Comparative Examples, which had been adjusted to 20° C., was applied evenly to the entire face under conditions of room temperature of 20° C. and humidity of 60%, and the skin cosmetics were evaluated by sensory evaluation as to whether or not they felt sticky.
<Evaluation criteria>
5: 13 or more out of 15 people did not feel sticky.
4: Between 10 and 12 out of 15 people did not feel sticky.
3: Between 7 and 9 out of 15 people did not feel sticky.
2: Between 4 and 6 out of 15 people did not feel sticky.
1: Less than 3 out of 15 people did not feel sticky.
「しっとり感の持続」
実施例および比較例で得られた皮膚化粧料のしっとり感の持続を専門のパネラー15人で評価試験を行った。評価試験は、20℃に調温した実施例および比較例の皮膚化粧料1gを室温20℃、湿度60%の条件下で顔全体に均一に塗布し、そのまま6時間肌に触れずに待機した後にしっとり感を感じたか否かを官能にて評価した。
<評価基準>
5:15人中13人以上がしっとり感が持続していると感じた。
4:15人中10人以上12人以下がしっとり感が持続していると感じた。
3:15人中7人以上9人以下がしっとり感が持続していると感じた。
2:15人中4人以上6人以下がしっとり感が持続していると感じた。
1:15人中3人以下がしっとり感が持続していると感じた。
"Sustained moisturizing effect"
The moisturizing effect of the skin cosmetics obtained in the Examples and Comparative Examples was evaluated by a panel of 15 experts. The evaluation test consisted of applying 1 g of the skin cosmetics of the Examples and Comparative Examples, which had been adjusted to 20° C., evenly over the entire face under conditions of room temperature of 20° C. and humidity of 60%, and leaving the skin unattended for 6 hours, after which the panelists evaluated whether or not the skin felt moisturized.
<Evaluation criteria>
5: More than 13 out of 15 people felt that the moist feeling lasted.
4: Between 10 and 12 out of 15 people felt that the moist feeling lasted.
3: Between 7 and 9 out of 15 people felt that the moist feeling lasted.
2: Between 4 and 6 out of 15 people felt that the moist feeling lasted.
1: Less than 3 out of 15 people felt that the moist feeling lasted.
表1~表5に示す実施例1~39より、塗布時の厚み、肌へのなじみ、のびの良さ、べたつきのなさおよびしっとり感の持続に関して良好な結果が得られた。 Examples 1 to 39 shown in Tables 1 to 5 showed good results in terms of thickness when applied, compatibility with the skin, ease of spreading, lack of stickiness, and sustained moisturizing sensation.
以下に皮膚化粧料の実施例40を記載する。 Example 40 of the skin cosmetic is described below.
以下の実施例により得られた皮膚化粧料は、塗布時の厚み、肌へのなじみ、のびの良さ、べたつきのなさおよびしっとり感の持続に関して良好な結果が得られた。 The skin cosmetics obtained in the following examples showed good results in terms of thickness when applied, compatibility with the skin, spreadability, non-stickiness, and sustained moisturizing effect.
<実施例40>
成 分 含有量(質量%)
(A)(アクリロイルジメチルタウリンアンモニウム/VP)コポリマー 0.10
(B)(アクリロイルジメチルタウリンアンモニウム/
メタクリル酸ベヘネス-25)クロスポリマー 0.10
(B)(アクリレーツ/アクリル酸アルキル(C10-30))
クロスポリマー 0.20
(C)メチルグルセス-10 2.00
(D)ミリスチルアルコール 0.50
ミリスチン酸オクチルドデシル 4.00
スクワラン 1.00
モノステアリン酸ソルビタン 0.20
メチルポリシロキサン 2.00
エデト酸二ナトリウム 0.05
トリメチルグリシン 2.00
1, 3-ブチレングリコール 10.00
パラオキシ安息香酸メチル 0.30
濃グリセリン 3.00
ジプロピレングリコール 7.00
ベルガモット果実油 0.01
ローズマリー油 0.01
L-アルギニン 0.20
ビルベリー葉エキス 0.01
セイヨウハッカエキス 0.01
カモミラエキス(1) 0.01
ローズマリーエキス 0.01
ユキノシタエキス 0.01
セイヨウサンザシエキス 0.01
アルニカエキス 0.01
エタノール 0.01
香料 0.40
精製水 66.85
合計 100.00
<Example 40>
Component Content (mass%)
(A) (Acryloyldimethyltaurate ammonium/VP) copolymer 0.10
(B) (ammonium acryloyldimethyltaurate /
Beheneth-25) methacrylate crosspolymer 0.10
(B) (Acrylates/Alkyl Acrylates (C10-30))
Crosspolymer 0.20
(C) Methyl gluceth-10 2.00
(D) Myristyl alcohol 0.50
Octyldodecyl myristate 4.00
Squalane 1.00
Sorbitan monostearate 0.20
Methylpolysiloxane 2.00
Disodium edetate 0.05
Trimethylglycine 2.00
1,3-butylene glycol 10.00
Methyl parahydroxybenzoate 0.30
Concentrated glycerin 3.00
Dipropylene glycol 7.00
Bergamot fruit oil 0.01
Rosemary oil 0.01
L-Arginine 0.20
Bilberry Leaf Extract 0.01
Peppermint extract 0.01
Chamomilla Extract (1) 0.01
Rosemary extract 0.01
Saxifrage extract 0.01
Hawthorn extract 0.01
Arnica extract 0.01
Ethanol 0.01
Fragrance 0.40
Purified water 66.85
Total 100.00
本発明により、塗布時の厚みがあり、肌へのなじみとのびが良好であり、べたつかず、しっとり感が持続する皮膚化粧料を得ることができる。 The present invention makes it possible to obtain a skin cosmetic that is thick when applied, spreads well on the skin, is not sticky, and provides a long-lasting moist feeling.
Claims (2)
(B)(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマーおよび(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー
(C)アルキルグルコシド誘導体
(D)炭素数12~24の高級アルコール
を含有し、前記(A)成分の含有量が0.01~1質量%であり、前記(B)成分の含有量が0.01~1質量%であり、前記(C)成分の含有量が0.1~15質量%であり、前記(D)成分の含有量が0.05~4質量%である皮膚化粧料。 (A) Ammonium acryloyldimethyltaurate/VP copolymer (B) Ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer and acrylates/C10-30 alkyl acrylate crosspolymer
A skin cosmetic comprising (C) an alkyl glucoside derivative and (D) a higher alcohol having 12 to 24 carbon atoms , the content of the component (A) being 0.01 to 1 mass%, the content of the component (B) being 0.01 to 1 mass%, the content of the component (C) being 0.1 to 15 mass%, and the content of the component (D) being 0.05 to 4 mass% .
2. The skin cosmetic preparation according to claim 1 , wherein the component (C) is one or more selected from methyl gluceth-10, methyl gluceth-20, PPG-10 methyl glucose, and PPG-20 methyl glucose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020196136A JP7570677B2 (en) | 2020-11-26 | 2020-11-26 | Skin cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020196136A JP7570677B2 (en) | 2020-11-26 | 2020-11-26 | Skin cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022084331A JP2022084331A (en) | 2022-06-07 |
| JP7570677B2 true JP7570677B2 (en) | 2024-10-22 |
Family
ID=81868141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020196136A Active JP7570677B2 (en) | 2020-11-26 | 2020-11-26 | Skin cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7570677B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7835436B2 (en) * | 2022-06-15 | 2026-03-25 | 株式会社ダリヤ | Emulsified composition for skin |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014520804A (en) | 2011-07-07 | 2014-08-25 | イーエルシー マネージメント エルエルシー | Methods and compositions useful for treating Fitzpatrick type IV, V or VI skin |
| JP2019172606A (en) | 2018-03-28 | 2019-10-10 | 株式会社ダリヤ | Skin emulsion cosmetics |
-
2020
- 2020-11-26 JP JP2020196136A patent/JP7570677B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014520804A (en) | 2011-07-07 | 2014-08-25 | イーエルシー マネージメント エルエルシー | Methods and compositions useful for treating Fitzpatrick type IV, V or VI skin |
| JP2019172606A (en) | 2018-03-28 | 2019-10-10 | 株式会社ダリヤ | Skin emulsion cosmetics |
Non-Patent Citations (6)
| Title |
|---|
| HACCI's JAPAN,HACCI 1912 アクアUV 2017,Cosmetic-Info.jp [online],2017年03月03日,Internet <URL:https://www.cosmetic-info.jp/prod/detail.php?id=49052>,[検索日:2024.06.21], 商品詳細 |
| IHC,Laeisisミルキーエマルジョン,Cosmetic-Info.jp [online],2019年11月07日,Internet <URL:https://www.cosmetic-info.jp/prod/detail.php?id=49052>,[検索日:2024.06.21], 商品詳細 |
| International Laboratories, Thailand,Sun Body UVA/UVB Protector SPF 40 PA++,Mintel GNPD [online],2020年06月,Internet <URL:https://portal.mintel.com>,ID#7899867, [検索日:2024.06.21], 表題部分,成分 |
| The Face Shop, South Korea,Serine Tone Smoothing Serum,Mintel GNPD [online],2020年09月,Internet <URL:https://portal.mintel.com>,ID#8072047, [検索日:2024.06.21], 表題部分,成分 |
| The Saem International, South Korea,Eye Serum EX,Mintel GNPD [online],2019年01月,Internet <URL:https://portal.mintel.com>,ID#6280399, [検索日:2024.06.21], 表題部分,成分 |
| Unilever, Mexico,Non-Greasy Moisturizing Gel,Mintel GNPD [online],2020年10月,Internet <URL:https://portal.mintel.com>,ID#8207811, [検索日:2024.06.21], 表題部分,成分 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022084331A (en) | 2022-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001213754A (en) | Cosmetics | |
| KR100356553B1 (en) | Emulsion comprising a hydrophilic thickening compound and a polysaccharide alkyl ether, compositions comprising the said emulsion, and uses | |
| JP2019172606A (en) | Skin emulsion cosmetics | |
| JPH01190614A (en) | Skin cosmetic | |
| JP5892720B2 (en) | Skin preparation | |
| JP7570677B2 (en) | Skin cosmetics | |
| JP7810420B2 (en) | Hair cosmetics | |
| JP7377526B2 (en) | Skin cosmetic composition | |
| JP4332062B2 (en) | Water-in-oil whitening cosmetic | |
| JP2000239139A (en) | Skin cosmetic | |
| JP7721106B2 (en) | Skin cosmetics | |
| JP2024103074A (en) | Oil-in-water sunscreen cosmetics | |
| JP6342186B2 (en) | Gel composition | |
| JP4896566B2 (en) | Cosmetics | |
| JP7132621B2 (en) | Skin cosmetics | |
| JP7835436B2 (en) | Emulsified composition for skin | |
| JP7214075B2 (en) | cosmetic composition | |
| JP2003012476A (en) | Semisolid hair cosmetic | |
| JP2002275027A (en) | Cosmetic and cosmetic impregnated in nonwoven fabric | |
| JP7217520B2 (en) | Skin cosmetics | |
| JP7778353B2 (en) | Gel cosmetics | |
| JP7504431B2 (en) | Hair styling composition | |
| JP2001199865A (en) | Bleaching cosmetic | |
| JP7504432B2 (en) | Skin cosmetics | |
| JP7523963B2 (en) | Skin cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230808 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240628 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240702 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240710 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20241001 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241002 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7570677 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |